Related Experiment Videos
Gangliosides and atherosclerosis
1Institute of Experimental Cardiology, Academy of Medical Sciences, Moscow, Russia.
Lipids
|January 1, 1994
Summary
Elevated gangliosides in aorta and serum may increase atherosclerosis risk. These molecules promote platelet activation and alter low-density lipoprotein (LDL) interactions with cells, potentially hindering LDL clearance and promoting uptake by macrophages.
Area of Science:
- Biochemistry
- Cardiovascular Biology
- Atherosclerosis Research
Background:
- Ganglioside levels are elevated in atherosclerotic lesions and serum of patients.
- Aortic gangliosides may play a role in platelet activation and adhesion.
- The impact of gangliosides on low-density lipoprotein (LDL) metabolism is under investigation.
Purpose of the Study:
- To review current findings on the role of aortic gangliosides in atherosclerosis.
- To explore the effects of gangliosides on platelet function and LDL interactions.
- To assess the potential of elevated gangliosides as an atherosclerosis risk factor.
Main Methods:
- Review of existing literature on gangliosides in atherosclerosis.
- In vitro experiments examining ganglioside effects on platelets and LDL.
- Analysis of ganglioside-modified LDL interactions with macrophages and hepatic cells.
Main Results:
- Aortic gangliosides promote platelet adhesion, aggregation, and spreading.
- Gangliosides modify LDL structure, enhancing aggregation.
- Ganglioside-modified LDL uptake by macrophages is increased, while hepatic clearance is inhibited.
- High ganglioside levels may represent an additional atherosclerosis risk factor.
Conclusions:
- Aortic gangliosides contribute to atherogenesis by influencing platelet behavior and LDL metabolism.
- Altered LDL processing due to gangliosides may promote macrophage accumulation.
- Elevated serum and aortic gangliosides are postulated as a risk factor for atherosclerosis.